The impact of a pediatric medical home on immunization coverage

A N Ortega1, D C Stewart, S A Dowshen

  • 1Yale University, Department of Epidemiology and Public Health, New Haven, Connecticut 06520-8034, USA.

Clinical Pediatrics
|March 4, 2000
PubMed

Insights

Access to a "medical home" did not improve immunization rates in children. Factors like race, insurance, and income significantly impact immunization outcomes, suggesting medical homes alone are insufficient for improving preventive care.

Area of Science:

  • Pediatrics
  • Public Health
  • Health Services Research

Background:

  • The "medical home" model aims to improve child healthcare access and coordination.
  • Understanding factors influencing age-appropriate immunization is crucial for child health.
  • Previous research suggests various socioeconomic factors affect preventive service utilization.

Purpose of the Study:

  • To evaluate the association between access to medical home provisions and age-appropriate immunization status in young children.
  • To identify key determinants of immunization coverage at 3, 12, and 24 months of age.

Main Methods:

  • Cross-sectional study design utilizing data from 495 children in Delaware.
  • Data collected between June 1994 and June 1995.
  • Immunization status ascertained using the Delaware immunization registry.

Main Results:

  • No significant association was found between the medical home concept and immunization coverage.
  • Race, insurance status, maternal education, and family income were identified as significant predictors of poor immunization outcomes.
  • Children with specific demographic and socioeconomic profiles were more likely to have suboptimal immunization rates.

Conclusions:

  • The provision of medical homes alone may not be a sufficient strategy to enhance immunization rates.
  • Addressing socioeconomic disparities, including race, insurance, education, and income, is critical for improving preventive service uptake.
  • Further research is needed to develop comprehensive strategies that effectively improve childhood immunization coverage.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Primary Healthcare Services01:30

Primary Healthcare Services

Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
Specialized Care Centers and Settings-II01:30

Specialized Care Centers and Settings-II

Rural Health Centers
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...